[The effects of TA-064, dopamine and isoproterenol on the acutely ischemic myocardium]. 1985

E Tokutake, and I Watanabe, and T Saito, and K Hibiya, and N Takahasi, and T Ogura, and S Yumikura, and M Nagasawa, and S Saito, and Y Ozawa

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

E Tokutake, and I Watanabe, and T Saito, and K Hibiya, and N Takahasi, and T Ogura, and S Yumikura, and M Nagasawa, and S Saito, and Y Ozawa
August 1986, Kokyu to junkan. Respiration & circulation,
E Tokutake, and I Watanabe, and T Saito, and K Hibiya, and N Takahasi, and T Ogura, and S Yumikura, and M Nagasawa, and S Saito, and Y Ozawa
October 1989, Journal of cardiovascular pharmacology,
E Tokutake, and I Watanabe, and T Saito, and K Hibiya, and N Takahasi, and T Ogura, and S Yumikura, and M Nagasawa, and S Saito, and Y Ozawa
October 1978, Circulation,
E Tokutake, and I Watanabe, and T Saito, and K Hibiya, and N Takahasi, and T Ogura, and S Yumikura, and M Nagasawa, and S Saito, and Y Ozawa
March 1976, The American journal of cardiology,
E Tokutake, and I Watanabe, and T Saito, and K Hibiya, and N Takahasi, and T Ogura, and S Yumikura, and M Nagasawa, and S Saito, and Y Ozawa
August 1990, The American surgeon,
E Tokutake, and I Watanabe, and T Saito, and K Hibiya, and N Takahasi, and T Ogura, and S Yumikura, and M Nagasawa, and S Saito, and Y Ozawa
March 1987, Japanese circulation journal,
E Tokutake, and I Watanabe, and T Saito, and K Hibiya, and N Takahasi, and T Ogura, and S Yumikura, and M Nagasawa, and S Saito, and Y Ozawa
October 1980, The American journal of physiology,
E Tokutake, and I Watanabe, and T Saito, and K Hibiya, and N Takahasi, and T Ogura, and S Yumikura, and M Nagasawa, and S Saito, and Y Ozawa
July 1989, Canadian journal of physiology and pharmacology,
E Tokutake, and I Watanabe, and T Saito, and K Hibiya, and N Takahasi, and T Ogura, and S Yumikura, and M Nagasawa, and S Saito, and Y Ozawa
September 1968, The American journal of cardiology,
E Tokutake, and I Watanabe, and T Saito, and K Hibiya, and N Takahasi, and T Ogura, and S Yumikura, and M Nagasawa, and S Saito, and Y Ozawa
March 1983, The American journal of cardiology,
Copied contents to your clipboard!